Cargando…

Histological analysis of hypoglycemic agents on liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review

Detalles Bibliográficos
Autores principales:	Xie, Qingxing, Pan, Xiaohui, Zhang, Xinyue, Ma, Jinfang, Peng, Ge, Tong, Nanwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431573/ https://www.ncbi.nlm.nih.gov/pubmed/37464470 http://dx.doi.org/10.1097/CM9.0000000000002778

Ejemplares similares

Commentary on “Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease”
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease?
por: Agilli, Mehmet, et al.
Publicado: (2014)

Association of serum zinc-α2-glycoprotein with non-alcoholic fatty liver disease
por: Qi, Xiao-Yan, et al.
Publicado: (2020)

Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis
por: Liu, Su-Tong, et al.
Publicado: (2020)

Underestimation of metabolic unhealthiness and overestimation of non-alcoholic fatty liver disease
por: Sarathi, Vijaya, et al.
Publicado: (2023)

The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B.
Publicado: (2014)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Han, Seul Ki, et al.
Publicado: (2023)

Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves’ disease: a systemic review
por: Xie, Qingxing, et al.
Publicado: (2023)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Clinical characteristics and pre-surgery diagnostic criteria of aldosterone-producing adrenocortical carcinoma
por: Zhang, Xinyi, et al.
Publicado: (2022)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
por: Soon, Gwyneth, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

Swansea criteria score in acute fatty liver of pregnancy
por: Tan, Jianbo, et al.
Publicado: (2022)

Comparison of clinical features and liver histology in liver failure caused by autoimmune hepatitis with different prognosis
por: Wu, Huili, et al.
Publicado: (2022)

Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19
por: Ji, Dong, et al.
Publicado: (2021)

Alcohol as an Ætiological Factor in Cirrhosis of the Liver
por: Ghosh, Nishanath
Publicado: (1922)

Current ultrasound-related strategies for assessing liver fibrosis in chronic liver disease
por: Xue, Li-Yun, et al.
Publicado: (2020)

Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Honda, Yasushi, et al.
Publicado: (2020)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
por: Nascimbeni, Fabio, et al.
Publicado: (2016)

Liver fibrosis and adverse outcomes in COVID-19
por: Huang, Jianmin
Publicado: (2021)

The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
por: Jung, Chan-Hee, et al.
Publicado: (2019)

Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals
por: Sun, Zewen, et al.
Publicado: (2023)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
por: Challa, Tenagne D, et al.
Publicado: (2019)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Hypoglycemic encephalopathy caused by overdose of metformin in an adolescent
por: Li, Jing-Xue, et al.
Publicado: (2020)

Association between folate and non-alcoholic fatty liver disease among US adults: a nationwide cross-sectional analysis
por: Liu, Zhening, et al.
Publicado: (2023)

Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Insulin Resistance and Genetic Risk Predict Liver‐Related Outcomes and Death in Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2019)

Association between hypoglycemic agent use and the risk of occurrence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Jung, Choungwon, et al.
Publicado: (2023)

The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)
por: D'Ambrosio, Roberta, et al.
Publicado: (2021)

Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Giraudi, Pablo J., et al.
Publicado: (2022)

Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
por: Wang, Jincheng, et al.
Publicado: (2022)

Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
por: Cheah, Mark CC, et al.
Publicado: (2017)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Olteanu, Vasile-Andrei, et al.
Publicado: (2022)

Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
por: Zeybel, Müjdat, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ui5mlfhvo6pvjhbbg36uhn5gbj